CEO: Kevin Sayer
GAAP Net loss: $127.1 million in 2018; $50.2 million in 2017
Headquarters: San Diego
Stock symbol and exchange: DXCM on Nasdaq
Company description: Dexcom’s flagship product is its G6 diabetes monitoring system, which doesn’t require finger prick blood draws for calibration.
Dexcom will lay off 350 workers largely in San Diego and Arizona as part of a restructuring, a move disclosed along with fourth quarter earnings that showed strong topline growth...